TTD Drug ID: DNC006022

Drug Information
Name	N-(4-morpholinophenyl)docos-13-enamide
Indication	Not Available			Experimental
Structure	Click to save drug structure in 3D MOL format Click to save drug structure in 2D MOL format
InChI	1S/C32H54N2O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20 -21-32(35)33-30-22-24-31(25-23-30)34-26-28-36-29-27-34/h9-10,22-2 5H,2-8,11-21,26-29H2,1H3,(H,33,35)/b10-9-
InChIKey	BNCLSGYMSOUADZ-KTKRTIGZSA-N
Canonical SMILES	CCCCCCCCC=CCCCCCCCCCCCC(=O)NC1=CC=C(C=C1)N2CCOCC2
Isomeric SMILES	CCCCCCCC/C=C\CCCCCCCCCCCC(=O)NC1=CC=C(C=C1)N2CCOCC2
Target	Cannabinoid CB1 receptor			Inhibitor	[1]
Ref 1	Bioorg Med Chem Lett. 2006 Jan 1;16(1):138-41. Epub 2005 Oct 6.New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.